Castle Biosciences Announced The Publication Of Two Recent Studies That Provide Further Support For The Clinical Need Of Its MyPath Melanoma Gene Expression Profile Test Designed To Aid In Providing An Accurate Diagnosis For Ambiguous Melanocytic Lesions
Castle Biosciences Announced The Publication Of Two Recent Studies That Provide Further Support For The Clinical Need Of Its MyPath Melanoma Gene Expression Profile Test Designed To Aid In Providing An Accurate Diagnosis For Ambiguous Melanocytic Lesions
castle biosciences宣佈發表了兩項最新研究，進一步支持其MyPath黑色素瘤基因表達譜檢測的臨床必要性，該檢測旨在幫助提供對於模糊黑色素細胞病變的準確診斷
Castle Biosciences Announced The Publication Of Two Recent Studies That Provide Further Support For The Clinical Need Of Its MyPath Melanoma Gene Expression Profile Test Designed To Aid In Providing An Accurate Diagnosis For Ambiguous Melanocytic Lesions
castle biosciences宣佈發表了兩項最新研究，進一步支持其MyPath黑色素瘤基因表達譜檢測的臨床必要性，該檢測旨在幫助提供對於模糊黑色素細胞病變的準確診斷
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間